Incyte to Present at Upcoming Investor Conference
Incyte (Nasdaq: INCY) announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference scheduled for Monday, June 10, 2024, at 8:00 a.m. (EDT) in Miami. The event will be webcast live and can be accessed via Investor.Incyte.com, with a replay available for 30 days.
- Incyte's participation in the Goldman Sachs event could enhance its visibility among investors.
- Webcasting the presentation live provides accessibility to a broader audience.
- The availability of a 30-day replay can attract more viewers who cannot attend the live event.
- The announcement lacks detailed updates on financial performance or clinical trials.
- No new products or strategic initiatives were mentioned, which might be seen as a missed opportunity to boost investor confidence.
The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.
About Incyte
A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in
For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240521754461/en/
Incyte Contacts
Media
media@incyte.com
Investors
ir@incyte.com
Source: Incyte
FAQ
When will Incyte present at the Goldman Sachs 45th Annual Global Healthcare Conference?
Where can I watch Incyte's presentation at the Goldman Sachs conference?
How long will the replay of Incyte's presentation be available?
What is the stock symbol for Incyte?
